Table 1.

Variations in contents of rosmarinic acid (RA) and salvianolic acid B (Sal B) from transgenic lines (ROS1-7, ROS1-14, ROS1-15 and DEL-9, DEL-15, DEL-16) and controls (CK−, WT; CK+, control from pCAMBIA1302 transformed lines) at different growth stages. *, ** and *** indicate that the difference is significant at p < 0.05, p < 0.01 and p < 0.001, between controls and transgenics.

Compound	CK−	CK+	ROS1-7	ROS1-14	ROS1-15	DEL-9	DEL-15	DEL-16
RA	63.35 ± 1.90 mg g−1	62.15 ± 2.51 mg g−1	95.38 ± 3.24 mg g−1 ***	113.28 ± 2.20 mg g−1 ***	94.50 ± 3.44 mg g−1 ***	72.21 ± 0.28 mg g−1 **	76.16 ± 0.84 mg g−1 ***	72.82 ± 0.41 mg g−1 **
Sal B	5.86 ± 0.10 mg g−1	5.71 ± 0.50 mg g−1	11.77 ± 1.24 mg g−1 ***	11.72 ± 0.93 mg g−1 ***	5.24 ± 0.61 mg g−1	8.55 ± 0.40 mg g−1 *	9.18 ± 0.18 mg g−1 **	8.54 ± 0.78 mg g−1 *